BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16826430)

  • 21. Sunitinib treatment reduces tumor growth and limits changes in microvascular properties after minor surgical intervention in an in vivo model of secondary breast cancer growth in bone.
    Schroeder M; Viezens L; Wellbrock J; Fiedler W; Rüther W; Algenstaedt P; Hansen-Algenstaedt N; Schaefer C
    J Surg Oncol; 2016 Apr; 113(5):515-21. PubMed ID: 26818116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
    Merz M; Komljenovic D; Semmler W; Bäuerle T
    Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
    Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
    Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
    Muraoka RS; Dumont N; Ritter CA; Dugger TC; Brantley DM; Chen J; Easterly E; Roebuck LR; Ryan S; Gotwals PJ; Koteliansky V; Arteaga CL
    J Clin Invest; 2002 Jun; 109(12):1551-9. PubMed ID: 12070302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
    Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
    Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
    Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
    J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
    Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
    Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary selenium supplementation modifies breast tumor growth and metastasis.
    Chen YC; Prabhu KS; Das A; Mastro AM
    Int J Cancer; 2013 Nov; 133(9):2054-64. PubMed ID: 23613334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary tumor-induced immunity suppresses bone metastases of breast cancer in syngeneic immunocompetent mouse models.
    Hiraga T; Nishida D; Horibe K
    Bone; 2024 Jan; 178():116944. PubMed ID: 37863157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of bone morphogenetic protein 4 (BMP4) on breast cancer metastasis in a mouse xenograft model.
    Ampuja M; Alarmo EL; Owens P; Havunen R; Gorska AE; Moses HL; Kallioniemi A
    Cancer Lett; 2016 Jun; 375(2):238-244. PubMed ID: 26970275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of Neovastat (AE-941) on an experimental metastatic bone tumor model.
    Weber MH; Lee J; Orr FW
    Int J Oncol; 2002 Feb; 20(2):299-303. PubMed ID: 11788892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
    Hiraga T; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 2001 Jun; 61(11):4418-24. PubMed ID: 11389070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
    Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
    Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel rodent mammary window of orthotopic breast cancer for intravital microscopy.
    Shan S; Sorg B; Dewhirst MW
    Microvasc Res; 2003 Mar; 65(2):109-17. PubMed ID: 12686168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
    Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
    Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
    Biochim Biophys Acta; 2014 Apr; 1843(4):815-26. PubMed ID: 24373848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.
    Welm AL; Sneddon JB; Taylor C; Nuyten DS; van de Vijver MJ; Hasegawa BH; Bishop JM
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7570-5. PubMed ID: 17456594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.